176 related articles for article (PubMed ID: 35288533)
21. Mitochondrial transporters of the SLC25 family and associated diseases: a review.
Palmieri F
J Inherit Metab Dis; 2014 Jul; 37(4):565-75. PubMed ID: 24797559
[TBL] [Abstract][Full Text] [Related]
22. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
23. Phylogenetic Analysis Guides Transporter Protein Deorphanization: A Case Study of the SLC25 Family of Mitochondrial Metabolite Transporters.
Byrne KL; Szeligowski RV; Shen H
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759714
[TBL] [Abstract][Full Text] [Related]
24. Recent Studies of Mitochondrial SLC25: Integration of Experimental and Computational Approaches.
Wang YJ; Khan FI; Xu Q; Wei DQ
Curr Protein Pept Sci; 2018; 19(5):507-522. PubMed ID: 27829346
[TBL] [Abstract][Full Text] [Related]
25. Expression mode and prognostic value of FXYD family members in colon cancer.
Jin M; Zhang H; Yang J; Zheng Z; Liu K
Aging (Albany NY); 2021 Jul; 13(14):18404-18422. PubMed ID: 34270462
[TBL] [Abstract][Full Text] [Related]
26. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
27. Discoveries, metabolic roles and diseases of mitochondrial carriers: A review.
Palmieri F; Monné M
Biochim Biophys Acta; 2016 Oct; 1863(10):2362-78. PubMed ID: 26968366
[TBL] [Abstract][Full Text] [Related]
28. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
[TBL] [Abstract][Full Text] [Related]
29. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
30. Identification of hub genes in colon cancer via bioinformatics analysis.
Liu J; Sun GL; Pan SL; Qin MB; Ouyang R; Huang JA
J Int Med Res; 2020 Sep; 48(9):300060520953234. PubMed ID: 32961078
[TBL] [Abstract][Full Text] [Related]
31. Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells.
Charepalli V; Reddivari L; Radhakrishnan S; Vadde R; Agarwal R; Vanamala JK
J Nutr Biochem; 2015 Dec; 26(12):1641-9. PubMed ID: 26383537
[TBL] [Abstract][Full Text] [Related]
32. The mitochondrial solute carrier SLC25A5 at Xq24 is a novel candidate gene for non-syndromic intellectual disability.
Vandewalle J; Bauters M; Van Esch H; Belet S; Verbeeck J; Fieremans N; Holvoet M; Vento J; Spreiz A; Kotzot D; Haberlandt E; Rosenfeld J; Andrieux J; Delobel B; Dehouck MB; Devriendt K; Fryns JP; Marynen P; Goldstein A; Froyen G
Hum Genet; 2013 Oct; 132(10):1177-85. PubMed ID: 23783460
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
[TBL] [Abstract][Full Text] [Related]
34. Candidate genes involved in metastasis of colon cancer identified by integrated analysis.
Zhou Y; Zang Y; Yang Y; Xiang J; Chen Z
Cancer Med; 2019 May; 8(5):2338-2347. PubMed ID: 30884206
[TBL] [Abstract][Full Text] [Related]
35. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
36. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.
Dong S; Ding Z; Zhang H; Chen Q
Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719
[No Abstract] [Full Text] [Related]
37. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
38. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis.
Fang Z; Xu S; Xie Y; Yan W
World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161
[TBL] [Abstract][Full Text] [Related]
39. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of an immune-associated RNA-binding proteins signature to predict clinical outcomes and therapeutic responses in colon cancer patients.
Sun D; Yang KS; Chen JL; Wang ZB
World J Surg Oncol; 2021 Oct; 19(1):314. PubMed ID: 34702278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
